{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:51:40Z","timestamp":1791042700328,"version":"4.1.0"},"reference-count":126,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1097\/hjh.0b013e3282f4b3e6","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T16:03:32Z","timestamp":1236269012000},"page":"613-621","source":"Crossref","is-referenced-by-count":95,"title":["Primary aldosteronism: an update on screening, diagnosis and treatment"],"prefix":"10.1097","volume":"26","author":[{"given":"Gian Paolo","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achille Cesare","family":"Pessina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M","family":"Heagerty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-1-20210208","first-page":"253","article-title":"Part I. Painting background. Part II. Primary aldosteronism, a new clinical syndrome","volume":"116","author":"Conn","year":"1990","journal-title":"J Lab Clin Med"},{"key":"R3-1-20210208","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/jama.1965.03090030022005","article-title":"Normokalemic primary aldosteronism: a detectable cause of curable \u201cessential\u201d hypertension","volume":"193","author":"Conn","year":"1965","journal-title":"JAMA"},{"key":"R4-1-20210208","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/jama.1966.03100010077019","article-title":"Normokalemic primary aldosteronism: its masquerade as \u201cessential\u201d hypertension","volume":"195","author":"Conn","year":"1966","journal-title":"JAMA"},{"key":"R5-1-20210208","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1001\/jama.1964.03070160046009","article-title":"Plasma renin activity in primary aldosteronism","volume":"190","author":"Conn","year":"1964","journal-title":"JAMA"},{"key":"R6-1-20210208","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archinte.1969.00300120042007","article-title":"A concluding response","volume":"123","author":"Conn","year":"1969","journal-title":"Arch Intern Med"},{"key":"R7-1-20210208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11906-004-0001-0","article-title":"Primary aldosteronism: a needle in a haystack or a yellow cab on fifth avenue?","volume":"6","author":"Rossi","year":"2004","journal-title":"Curr Hypertens Rep"},{"key":"R8-1-20210208","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1440-1681.1993.tb01687.x","article-title":"Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers","volume":"20","author":"Gordon","year":"1993","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R9-1-20210208","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00004872-199405000-00015","article-title":"The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients","volume":"12","author":"Anderson","year":"1994","journal-title":"J Hypertens"},{"key":"R10-1-20210208","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension","volume":"21","author":"Gordon","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R11-1-20210208","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archinte.1996.00440100086010","article-title":"Prevalence of adrenal and extra-adrenal Conn syndrome in hypertensive patients","volume":"156","author":"Abdelhamid","year":"1996","journal-title":"Arch Intern Med"},{"key":"R12-1-20210208","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1445-5994.1996.tb00600.x","article-title":"Primary hyperaldosteronism: a missed diagnosis in \u2018essential hypertensives\u2019?","volume":"26","author":"Brown","year":"1996","journal-title":"Aust N Z J Med"},{"key":"R13-1-20210208","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1365-2265.1998.00608.x","article-title":"Screening for primary aldosteronism with a logistic multivariate discriminant analysis","volume":"49","author":"Rossi","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R14-1-20210208","first-page":"800","article-title":"High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension","volume":"127","author":"Mosso","year":"1999","journal-title":"Rev Med Chil"},{"key":"R15-1-20210208","first-page":"394","article-title":"The aldosterone\/renin ratio as a screening test for primary aldosteronism","volume":"90","author":"Rayner","year":"2000","journal-title":"S Afr Med J"},{"key":"R16-1-20210208","first-page":"2854","article-title":"Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore","volume":"85","author":"Loh","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-1-20210208","first-page":"1037","article-title":"What tests should be conducted for secondary arterial hypertension in hypertensive patients resistant to treatment?","volume":"93","author":"Denolle","year":"2000","journal-title":"Arch Mal Coeur Vaiss"},{"key":"R18-1-20210208","first-page":"955","article-title":"Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach","volume":"128","author":"Cortes","year":"2000","journal-title":"Rev Med Chil"},{"issue":"Suppl 1","key":"R19-1-20210208","doi-asserted-by":"crossref","first-page":"83s","DOI":"10.1016\/S0753-3322(00)80019-0","article-title":"Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital","volume":"54","author":"Nishikawa","year":"2000","journal-title":"Biomed Pharmacother"},{"key":"R20-1-20210208","first-page":"1863","article-title":"Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology","volume":"85","author":"Fardella","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R21-1-20210208","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.jhh.1001013","article-title":"High prevalence of primary aldosteronism in the Tayside hypertension clinic population","volume":"14","author":"Lim","year":"2000","journal-title":"J Hum Hypertens"},{"key":"R22-1-20210208","first-page":"594","article-title":"Screening for primary aldosteronism: normal ranges for aldosterone and renin in three South African population groups","volume":"91","author":"Rayner","year":"2001","journal-title":"S Afr Med J"},{"key":"R23-1-20210208","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"R24-1-20210208","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/clinchem\/48.11.1919","article-title":"Screening for primary aldosteronism: implications of an increased plasma aldosterone\/renin ratio","volume":"48","author":"Schwartz","year":"2002","journal-title":"Clin Chem"},{"key":"R25-1-20210208","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0895-7061(02)02969-2","article-title":"High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives","volume":"15","author":"Rossi","year":"2002","journal-title":"Am J Hypertens"},{"key":"R26-1-20210208","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.jhh.1001948","article-title":"Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia","volume":"20","author":"Williams","year":"2006","journal-title":"J Hum Hypertens"},{"key":"R27-1-20210208","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R28-1-20210208","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/01.hjh.0000217857.20241.0f","article-title":"Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol","volume":"24","author":"Giacchetti","year":"2006","journal-title":"J Hypertens"},{"key":"R29-1-20210208","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/HJH.0b013e3280127973","article-title":"To stimulate or not to stimulate: is adrenocorticotrophic hormone testing necessary, or not?","volume":"25","author":"Rossi","year":"2007","journal-title":"J Hypertens"},{"key":"R30-1-20210208","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11906-003-0012-2","article-title":"Aldosterone: a risk factor for vascular disease","volume":"5","author":"Fritsch","year":"2003","journal-title":"Curr Hypertens Rep"},{"key":"R31-1-20210208","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/01.HYP.0000078357.92682.EC","article-title":"Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling","volume":"42","author":"Pu","year":"2003","journal-title":"Hypertension"},{"issue":"Suppl D","key":"R32-1-20210208","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/eurheartj\/13.suppl_D.24","article-title":"Myocardial collagen matrix remodelling in arterial hypertension","volume":"13","author":"Brilla","year":"1992","journal-title":"Eur Heart J"},{"key":"R33-1-20210208","first-page":"127","article-title":"Pharmacological modulation of cardiac fibroblast function","volume":"20","author":"Brilla","year":"1995","journal-title":"Herz"},{"key":"R34-1-20210208","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","article-title":"Remodeling of the rat right and left ventricles in experimental hypertension","volume":"67","author":"Brilla","year":"1990","journal-title":"Circ Res"},{"key":"R35-1-20210208","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1210\/en.2002-220120","article-title":"Selective aldosterone blockade prevents angiotensin II\/salt-induced vascular inflammation in the rat heart","volume":"143","author":"Rocha","year":"2002","journal-title":"Endocrinology"},{"key":"R36-1-20210208","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R37-1-20210208","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1749-6632.2002.tb04415.x","article-title":"The pathophysiology of aldosterone in the cardiovascular system","volume":"970","author":"Rocha","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"R38-1-20210208","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2165\/00003495-200262050-00001","article-title":"Rationale for the use of aldosterone antagonists in congestive heart failure","volume":"62","author":"Rocha","year":"2002","journal-title":"Drugs"},{"key":"R39-1-20210208","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1043-2760(01)00432-5","article-title":"Pathophysiological effects of aldosterone in cardiovascular tissues","volume":"12","author":"Rocha","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"R40-1-20210208","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/endo.141.10.7711","article-title":"Aldosterone: a mediator of myocardial necrosis and renal arteriopathy","volume":"141","author":"Rocha","year":"2000","journal-title":"Endocrinology"},{"key":"R41-1-20210208","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.33.1.232","article-title":"Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats","volume":"33","author":"Rocha","year":"1999","journal-title":"Hypertension"},{"key":"R42-1-20210208","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","article-title":"Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats","volume":"31","author":"Rocha","year":"1998","journal-title":"Hypertension"},{"issue":"Suppl 8","key":"R43-1-20210208","first-page":"S147","article-title":"Left ventricular systolic function in primary aldosteronism and hypertension","volume":"19","author":"Rossi","year":"1997","journal-title":"J Hypertens"},{"key":"R44-1-20210208","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.CIR.95.6.1471","article-title":"Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma","volume":"95","author":"Rossi","year":"1997","journal-title":"Circulation"},{"key":"R45-1-20210208","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1097\/HJH.0b013e3281268532","article-title":"Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension","volume":"25","author":"Holaj","year":"2007","journal-title":"J Hypertens"},{"key":"R46-1-20210208","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/01.HYP.31.1.335","article-title":"Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure","volume":"31","author":"Rizzoni","year":"1998","journal-title":"Hypertension"},{"key":"R47-1-20210208","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0735-1097(98)00322-2","article-title":"Relations between cardiac and vascular structure in patients with primary and secondary hypertension","volume":"32","author":"Rizzoni","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"R48-1-20210208","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/08037059209077510","article-title":"Fibrosis of the human heart and systemic organs in adrenal adenoma","volume":"1","author":"Campbell","year":"1992","journal-title":"Blood Press"},{"key":"R49-1-20210208","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.HYP.0000023182.68420.EB","article-title":"Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism","volume":"40","author":"Rossi","year":"2002","journal-title":"Hypertension"},{"key":"R50-1-20210208","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.HYP.0000052542.68896.2B","article-title":"Myocardial ultrasonic backscatter in hypertension: relation to aldosterone and endothelin","volume":"41","author":"Kozakova","year":"2003","journal-title":"Hypertension"},{"key":"R51-1-20210208","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/00004872-200207000-00032","article-title":"Structural changes in small resistance arteries and left ventricular geometry in patients with primary and secondary hypertension","volume":"20","author":"Muiesan","year":"2002","journal-title":"J Hypertens"},{"key":"R52-1-20210208","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0272-6386(99)70298-2","article-title":"Cardiovascular complications in patients with primary aldosteronism","volume":"33","author":"Nishimura","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R53-1-20210208","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF03347840","article-title":"Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormones in Japan","volume":"18","author":"Takeda","year":"1995","journal-title":"J Endocrinol Invest"},{"key":"R54-1-20210208","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1097\/00004872-199512010-00054","article-title":"Albuminuria in untreated patients with primary aldosteronism or essential hypertension","volume":"13","author":"Halimi","year":"1995","journal-title":"J Hypertens"},{"key":"R55-1-20210208","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","article-title":"Renal Damage in Primary Aldosteronism: Results of the PAPY Study","volume":"48","author":"Rossi","year":"2006","journal-title":"Hypertension"},{"key":"R56-1-20210208","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","article-title":"Long-term renal outcomes in patients with primary aldosteronism","volume":"295","author":"Sechi","year":"2006","journal-title":"JAMA"},{"key":"R57-1-20210208","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/HYPERTENSIONAHA.106.086124","article-title":"Is there an unrecognized epidemic of primary aldosteronism? Con","volume":"50","author":"Kaplan","year":"2007","journal-title":"Hypertension"},{"key":"R58-1-20210208","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/HYPERTENSIONAHA.106.086116","article-title":"Is there an unrecognized epidemic of primary aldosteronism? Pro","volume":"50","author":"Calhoun","year":"2007","journal-title":"Hypertension"},{"key":"R59-1-20210208","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.tem.2005.02.007","article-title":"Diagnosis of primary aldosteronism: from screening to subtype differentiation","volume":"16","author":"Mulatero","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"R60-1-20210208","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tem.2005.02.006","article-title":"Plasma renin and aldosterone measurements in low renin hypertensive states","volume":"16","author":"Sealey","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"R61-1-20210208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408360600931831","article-title":"Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension","volume":"44","author":"Rossi","year":"2007","journal-title":"Crit Rev Clin Lab Sci"},{"key":"R62-1-20210208","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/01.HYP.37.6.1440","article-title":"Captopril suppression versus salt loading in confirming primary aldosteronism","volume":"37","author":"Agharazii","year":"2001","journal-title":"Hypertension"},{"key":"R63-1-20210208","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/01.HYP.0000014324.68506.CA","article-title":"Diagnostic value of the postcaptopril test in primary aldosteronism","volume":"39","author":"Castro","year":"2002","journal-title":"Hypertension"},{"key":"R64-1-20210208","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archinte.1971.00310210056004","article-title":"Saline suppression of plasma aldosterone in hypertension","volume":"128","author":"Kem","year":"1971","journal-title":"Arch Intern Med"},{"key":"R65-1-20210208","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.HYP.6.5.717","article-title":"Further evaluation of saline infusion for the diagnosis of primary aldosteronism","volume":"6","author":"Holland","year":"1984","journal-title":"Hypertension"},{"key":"R66-1-20210208","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.107.091827","article-title":"Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma","volume":"50","author":"Rossi","year":"2007","journal-title":"Hypertension"},{"key":"R67-1-20210208","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/HJH.0b013e328126856e","article-title":"Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma","volume":"25","author":"Rossi","year":"2007","journal-title":"J Hypertension"},{"key":"R68-1-20210208","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1210\/jcem.84.12.6256","article-title":"Glucocorticoid-remediable aldosteronism","volume":"84","author":"Dluhy","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R69-1-20210208","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1677\/erc.1.00867","article-title":"Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course","volume":"12","author":"Seccia","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"R70-1-20210208","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jso.2930280118","article-title":"Coexistence of aldosteronoma and pheochromocytoma in an adrenal gland","volume":"28","author":"Wajiki","year":"1985","journal-title":"J Surg Oncol"},{"key":"R71-1-20210208","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1440-1681.1994.tb02500.x","article-title":"An association of primary aldosteronism and adrenaline-secreting phaeochromocytoma","volume":"21","author":"Gordon","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R72-1-20210208","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2265.1996.709530.x","article-title":"Coexistence of bilateral adrenal phaeochromocytoma and idiopathic hyperaldosteronism","volume":"44","author":"Tan","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R73-1-20210208","first-page":"479","article-title":"Secondary hyperaldosteronism caused by cervical phaeochromocytoma cured by ablation of the tumor","volume":"35","author":"Mannhart","year":"1971","journal-title":"Helv Med Acta"},{"key":"R74-1-20210208","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-5347(17)66966-0","article-title":"A case of secondary aldosteronism induced by pheochromocytoma","volume":"114","author":"Kitajima","year":"1975","journal-title":"J Urol"},{"key":"R75-1-20210208","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00268-005-0594-8","article-title":"Primary hyperaldosteronism secondary to unilateral adrenal hyperplasia: an unusual cause of surgically correctable hypertension. A review of 30 cases","volume":"31","author":"Goh","year":"2007","journal-title":"World J Surg"},{"key":"R76-1-20210208","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1053\/meta.2002.30498","article-title":"Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling","volume":"51","author":"Omura","year":"2002","journal-title":"Metabolism"},{"key":"R77-1-20210208","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4158\/EP.6.2.153","article-title":"A case of unilateral adrenal hyperplasia: the diagnostic dilemma of hyperaldosteronism","volume":"6","author":"Haenel","year":"2000","journal-title":"Endocr Pract"},{"key":"R78-1-20210208","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1507\/endocrj.47.443","article-title":"Primary aldosteronism due to unilateral adrenal hyperplasia: report of two cases and review of the literature","volume":"47","author":"Morioka","year":"2000","journal-title":"Endocr J"},{"key":"R79-1-20210208","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1291\/hypres.28.379","article-title":"A case of primary aldosteronism due to unilateral adrenal hyperplasia","volume":"28","author":"Katayama","year":"2005","journal-title":"Hypertens Res"},{"key":"R80-1-20210208","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1507\/endocrj.52.435","article-title":"A case with primary aldosteronism due to unilateral multiple adrenocortical micronodules","volume":"52","author":"Hirono","year":"2005","journal-title":"Endocr J"},{"key":"R81-1-20210208","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1440-1681.1994.tb02520.x","article-title":"Response to unilateral adrenalectomy for aldosterone-producing adenoma: effect of potassium levels and angiotensin responsiveness","volume":"21","author":"Stowasser","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R82-1-20210208","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03349761","article-title":"Primary aldosteronism","volume":"18","author":"Gordon","year":"1995","journal-title":"J Endocrinol Invest"},{"key":"R83-1-20210208","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3317\/jraas.2001.022","article-title":"Diagnosis and management of primary aldosteronism","volume":"2","author":"Stowasser","year":"2001","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"R84-1-20210208","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R85-1-20210208","first-page":"357","article-title":"Imaging of aldosterone-secreting adenomas: a prospective comparison of computed tomography and magnetic resonance imaging in 27 patients with suspected primary aldosteronism","volume":"7","author":"Rossi","year":"1993","journal-title":"J Hum Hypertens"},{"key":"R86-1-20210208","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0895-7061(96)00506-7","article-title":"Coexistence of aldosteronoma and contralateral nonfunctioning adrenal adenoma in primary aldosteronism","volume":"10","author":"Fallo","year":"1997","journal-title":"Am J Hypertens"},{"key":"R87-1-20210208","first-page":"1066","article-title":"Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism","volume":"86","author":"Magill","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R88-1-20210208","first-page":"637","article-title":"A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology","volume":"85","author":"Mantero","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R89-1-20210208","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","article-title":"Role for adrenal venous sampling in primary aldosteronism","volume":"136","author":"Young","year":"2004","journal-title":"Surgery"},{"key":"R90-1-20210208","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1291\/hypres.29.883","article-title":"Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism","volume":"29","author":"Omura","year":"2006","journal-title":"Hypertens Res"},{"key":"R91-1-20210208","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11906-007-0017-3","article-title":"New concepts in adrenal vein sampling for aldosterone in the diagnosis of primary aldosteronism","volume":"9","author":"Rossi","year":"2007","journal-title":"Curr Hypertens Rep"},{"key":"R92-1-20210208","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM197602192940802","article-title":"Location of aldosterone-producing adenomas with 131I-19-iodocholesterol","volume":"294","author":"Hogan","year":"1976","journal-title":"N Engl J Med"},{"key":"R93-1-20210208","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1210\/jcem-71-4-825","article-title":"Iodomethylnorcholesterol uptake in an aldosteronoma shown by dexamethasone-suppresion scintigraphy: relationship to adenoma size and functional activity","volume":"71","author":"Nomura","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"R94-1-20210208","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000173946","article-title":"Primary aldosteronism: diagnosis and noninvasive lateralization procedures","volume":"72","author":"Vetter","year":"1985","journal-title":"Cardiology"},{"key":"R95-1-20210208","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0895-7061(01)02312-3","article-title":"Unilateral adrenal hyperplasia causing primary aldosteronism: limitations of I-131 norcholesterol scanning","volume":"15","author":"Mansoor","year":"2002","journal-title":"Am J Hypertens"},{"key":"R96-1-20210208","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00004872-200405000-00001","article-title":"The current epidemic of primary aldosteronism: causes and consequences","volume":"22","author":"Kaplan","year":"2004","journal-title":"J Hypertens"},{"key":"R97-1-20210208","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1681.1991.tb01446.x","article-title":"Clinical and pathological diversity of primary aldosteronism, including a new familial variety","volume":"18","author":"Gordon","year":"1991","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R98-1-20210208","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0960-0760(01)00097-8","article-title":"Familial hyperaldosteronism","volume":"78","author":"Stowasser","year":"2001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R99-1-20210208","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1210\/jcem-49-5-757","article-title":"A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol","volume":"49","author":"Ulick","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"R100-1-20210208","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tem.2005.02.011","article-title":"Monogenic low renin hypertension","volume":"16","author":"New","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"R101-1-20210208","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI113592","article-title":"Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle","volume":"82","author":"Stewart","year":"1988","journal-title":"J Clin Invest"},{"key":"R102-1-20210208","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(88)90742-8","article-title":"Localisation of 11 beta-hydroxysteroid dehydrogenase: tissue specific protector of the mineralocorticoid receptor","volume":"2","author":"Edwards","year":"1988","journal-title":"Lancet"},{"key":"R103-1-20210208","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","article-title":"Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated","volume":"242","author":"Funder","year":"1988","journal-title":"Science"},{"key":"R104-1-20210208","first-page":"2263","article-title":"A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess","volume":"80","author":"Wilson","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"R105-1-20210208","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/ng0895-394","article-title":"Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase","volume":"10","author":"Mune","year":"1995","journal-title":"Nat Genet"},{"key":"R106-1-20210208","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0140-6736(96)90211-1","article-title":"Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene","volume":"347","author":"Stewart","year":"1996","journal-title":"Lancet"},{"key":"R107-1-20210208","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/jcem-63-3-550","article-title":"The syndrome of apparent mineralocorticoid excess: its association with 11 beta-dehydrogenase and 5 beta-reductase deficiency and some consequences for corticosteroid metabolism","volume":"63","author":"Monder","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"R108-1-20210208","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(87)91014-2","article-title":"Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age","volume":"2","author":"Stewart","year":"1987","journal-title":"Lancet"},{"key":"R109-1-20210208","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJM199110243251706","article-title":"Licorice-induced hypermineralocorticoidism","volume":"325","author":"Farese","year":"1991","journal-title":"N Engl J Med"},{"key":"R110-1-20210208","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/367463a0","article-title":"Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits","volume":"367","author":"Canessa","year":"1994","journal-title":"Nature"},{"key":"R111-1-20210208","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0092-8674(94)90250-X","article-title":"Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel","volume":"79","author":"Shimkets","year":"1994","journal-title":"Cell"},{"key":"R112-1-20210208","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng0995-76","article-title":"Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome","volume":"11","author":"Hansson","year":"1995","journal-title":"Nat Genet"},{"key":"R113-1-20210208","doi-asserted-by":"crossref","first-page":"11495","DOI":"10.1073\/pnas.92.25.11495","article-title":"A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity","volume":"92","author":"Hansson","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R114-1-20210208","first-page":"500","article-title":"Molecular genetics of salt-sensitivity and hypertension","volume":"29","author":"Luft","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"R115-1-20210208","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1056\/NEJM199401203300305","article-title":"Brief report: Liddle's syndrome revisited: a disorder of sodium reabsorption in the distal tubule","volume":"330","author":"Botero-Velez","year":"1994","journal-title":"N Engl J Med"},{"key":"R116-1-20210208","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/01.HYP.32.1.129","article-title":"Genetic analysis of the beta subunit of the epithelial Na+ channel in essential hypertension","volume":"32","author":"Persu","year":"1998","journal-title":"Hypertension"},{"key":"R117-1-20210208","first-page":"G567","article-title":"Genetic disorders of membrane transport. V. The epithelial sodium channel and its implication in human diseases","volume":"276","author":"Hummler","year":"1999","journal-title":"Am J Physiol"},{"key":"R118-1-20210208","first-page":"503","article-title":"Laparoscopic versus open adrenalectomy: outcome in 35 consecutive patients","volume":"1","author":"Toniato","year":"2000","journal-title":"Int J Surg Investig"},{"key":"R119-1-20210208","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0090-4295(02)02240-9","article-title":"Laparoscopic partial adrenalectomy in patients with aldosterone-producing adenomas: indications, technique, and results","volume":"61","author":"Jeschke","year":"2003","journal-title":"Urology"},{"key":"R120-1-20210208","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0022-5347(05)64028-1","article-title":"Laparoscopic management of primary hyperaldosteronism: clinical experience with 212 cases","volume":"169","author":"Meria","year":"2003","journal-title":"J Urol"},{"key":"R121-1-20210208","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7326\/0003-4819-135-4-200108210-00010","article-title":"Primary aldosteronism: factors associated with normalization of blood pressure after surgery","volume":"135","author":"Sawka","year":"2001","journal-title":"Ann Intern Med"},{"key":"R122-1-20210208","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/000313480507101015","article-title":"Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature","volume":"71","author":"Lumachi","year":"2005","journal-title":"Am Surg"},{"key":"R123-1-20210208","first-page":"987","article-title":"Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism","volume":"112","author":"Obara","year":"1992","journal-title":"Surgery"},{"key":"R124-1-20210208","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1067\/msy.1998.93108","article-title":"Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism?","volume":"124","author":"Proye","year":"1998","journal-title":"Surgery"},{"key":"R125-1-20210208","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"R126-1-20210208","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"R127-1-20210208","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004872-200804000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T01:59:53Z","timestamp":1618365593000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-200804000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":126,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e3282f4b3e6","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}